Drugs / D-Galactose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01113385 | Oct 2009 → Mar 2013 | focal segmental glomerulosclerosis, steroid-resistant nephrotic syndrome | Children's National Research Institute | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-Galactose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01113385 ↗ |
| Action | Inhibit | “galactose, a simple milk sugar thought to bind to the protein factor (FSPF) that causes FSGS thereby inactivating it and stopping it from damaging the kidney” NCT01113385 ↗ |
| Modality | Small molecule | “a simple milk sugar” NCT01113385 ↗ |
| Route | Oral | “consumed orally” NCT01113385 ↗ |